Exabis Library
Welcome to the e-CCO Library!
P456: Ig glycosylation in ulcerative colitis: it's time for new biomarkers
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P456: Magnetic resonance enterography findings at week 46 after biological treatment predict long-term clinical outcomes in Crohn's disease patients
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P456: Quality of life is associated with wearable-based physical activity in patients with inflammatory bowel disease: a prospective, observational study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P456: Risk of malignant tumors in patients with autoimmune diseases on ustekinumab therapy: a systematic review and meta-analysis
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P457 IBD couples and their offspring: a European survey
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P457: Biological interventions for induction and maintenance of mucosal healing in ulcerative colitis: A Cochrane systematic review
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P457: Complications and disease recurrence after primary ileocecal resection in paediatric Crohn’s disease: a multicentre cohort analysis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P457: Influence of concomitant immunomodulators during maintenance therapy with Adalimumab in inflammatory bowel disease: looking for the ideal patient to use monotherapy
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P457: Long-term cumulative safety of ustekinumab in bionaive patients with Crohn’s Disease and Ulcerative Colitis
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P457: Long-term follow-up of patients with IBD after switching from original adalimumab to adalimumab biosimilar during COVID 19 pandemic
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P457: Rapid faecal calprotectin test and symptom index for monitoring the disease activity in colonic IBD
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P457: Treatment duration of ustekinumab in patients with Crohn's disease (CD) and psoriasis (PSO) – real-world evidence from German claims data
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P458 Association between adalimumab serum levels and level of remission in Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P458: Effect of cognitive behavioural therapy on clinical disease course in adolescents and young adults with inflammatory bowel disease and subclinical anxiety and/or depression: results of a randomised trial
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P458: Effectiveness of biological therapy for pouchitis and other inflammatory complications ot the pouch. And the question of a second Anti-TNF after failure? Results from the RESERVO Study of GETECCU.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P458: Long-term outcome of Crohn’s disease complicated by upper gastrointestinal stricture: A GETAID cohort study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P458: Low adherence to Mediterranean diet is associated with increased adipose tissue in patients with ulcerative colitis (UC) after pouch surgery: a cross sectional study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P458: Multidisciplinary working when developing the UK inflammatory bowel disease standards and IBD audit
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P458: Safety and Potential Efficacy of Escalating Dose of Ustekinumab in Pediatric Crohn's disease (the SPEED-UP study) - A multi-center study from the paediatric IBD Porto group of ESPGHAN
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P458: Sleep problems in inflammatory bowel disease; When bed becomes a battleground
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM